求助PDF
{"title":"Comparison of Incidence and Clinical Outcomes of COVID-19 among Healthcare Workers in the Prevaccination and Post-vaccination Periods: A Real-world Impact Study","authors":"S. Surme, B. Copur, O. Bayramlar, G. Tuncer, Y. Ozdemir, F. Pehlivanoğlu, G. Sengoz","doi":"10.4274/haseki.galenos.2022.8505","DOIUrl":null,"url":null,"abstract":"Aim: Real-life data on the effect of coronavirus disease-2019 (COVID-19) vaccination is limited. We aimed to compare the incidence of COVID-19 among healthcare workers (HCWs) in the pre-vaccination and post-vaccination periods during the COVID-19 pandemic and identify associated factors for COVID-19 development. Method(s): In this single-center and cross-sectional study, HCWs employed in a tertiary care hospital were included. Pre-vaccination (14 October, 2020 and 14 January, 2021) and post-vaccination periods (1 March, 2021 and 1 June, 2021) were compared. A subgroup analysis was performed on HCWs without a previous history of COVID-19. Additionally, univariate regression analysis of COVID-19 development in the post-vaccination period was performed. Result(s): Of 2,922 HCWs, 2,096 (71.7%) were vaccinated. The incidence of COVID-19 was higher in the pre-vaccination period (16.3%) than in the post-vaccination (6.6%) (p<0.01). In the subgroup analysis, the incidence of COVID-19 was 16.6% in the pre-vaccination period and 8.1% in the post-vaccination period (p<0.01). Previous history of COVID-19 (p<0.01) and double-dose vaccination (p<0.01) were associated with a decreased risk of COVID-19 development. Conclusion(s): This study demonstrates the real-life impact of COVID-19 vaccination in reducing disease development and preventing poor clinical outcomes in a setting where the vaccination rate among HCWs was fairly low. Copyright © 2022 by The Medical Bulletin of Istanbul Haseki Training and Research Hospital The Medical Bulletin of Haseki published by Galenos Yayinevi.","PeriodicalId":42416,"journal":{"name":"Haseki TIp Bulteni-Medical Bulletin of Haseki","volume":"6 1","pages":""},"PeriodicalIF":0.3000,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Haseki TIp Bulteni-Medical Bulletin of Haseki","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/haseki.galenos.2022.8505","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
引用
批量引用
预防接种和接种后医护人员COVID-19发病率和临床结果的比较:一项现实世界影响研究
目的:关于2019冠状病毒病(COVID-19)疫苗接种效果的实际数据有限。我们的目的是比较COVID-19大流行期间接种疫苗前和接种疫苗后医护人员(HCWs)的COVID-19发病率,并确定COVID-19发展的相关因素。方法:在这项单中心横断面研究中,纳入了在三级保健医院工作的医护人员。对接种前(2020年10月14日和2021年1月14日)和接种后(2021年3月1日和2021年6月1日)进行比较。对无COVID-19病史的医护人员进行亚组分析。此外,对疫苗接种后COVID-19的发展情况进行单因素回归分析。结果:2922名卫生保健员中,2096名(71.7%)接种了疫苗。新冠肺炎的发病率在接种前(16.3%)高于接种后(6.6%)(p<0.01)。亚组分析中,接种前和接种后的新冠肺炎发病率分别为16.6%和8.1% (p<0.01)。既往COVID-19病史(p<0.01)和双剂量疫苗接种(p<0.01)与COVID-19发展风险降低相关。结论:本研究证明了在卫生保健工作者疫苗接种率相当低的情况下,COVID-19疫苗接种在减少疾病发展和预防不良临床结果方面的现实影响。伊斯坦布尔Haseki培训和研究医院医学公报版权所有©2022。Galenos Yayinevi出版的Haseki医学公报。
本文章由计算机程序翻译,如有差异,请以英文原文为准。